PurposeTo describe our clinical experience with a system named SureShot™ Distal Targeting (Smith & Nephew, Memphis, USA) based on magnetic field presence and discuss our suggestions on this technique.MethodsWe analysed prospectively 47 patients affected by humeral, tibial or femoral fractures, treated in our institution during a 3-year period of time (August 2010 to September 2013). We considered the following parameters: the time to set up, the time to position a single screw, the effectiveness of the system (drilling ad screwing), the irradiation exposure time during distal locking procedure and surgical complications.ResultsA total number of 96 screws were inserted. The mean preparation time of the device was 5.1 min ± 2 min (range 3–10 min). The mean time for single screw targeting was 5.8 min ± 2.3 min (range 4–18 min). No major complications occurred. Only a few locking procedures were needed to be practiced in order to obtain the required expertise with this targeting device.ConclusionAccording to our results, this device is reliable and valid whenever the correct technique is followed. It is also user friendly, exposes to lower radiation and needs less surgical time compared to relative data from the literature. However, the surgeon should always be aware of how to use the free hand technique in case of malfunctioning of the system.
Orthopaedic management of fragility fractures: current state and perspectives Fragility fractures, and in particular those of the femoral neck, vertebrae, wrist and proximal humerus, are increasing, with a socio-economic impact strong enough to suggest modifications in their current management. These fractures are characterized by their time of event, clinical approach and functional results, which are also influenced by co-morbidity of the patient. However, in Italy, it was recently shown that patients hospitalized for hip fracture, as well as having an average age over 75, are averagely in their fourth fracturative episode. The high mortality rate usually associated to this type of fracture is significantly decreased when an anti-osteoporosis therapy is initiated. Given the increase of the elderly population in the coming years, and especially the octogenarians, it is necessary to implement a multidisciplinary therapeutic approach suitable to the recovery of a quality of life of the same level to the period preceding the fragility fracture. Therefore, during the first fragility fracture, the orthopedist is essential to implement an adjuvant drug therapy that promotes healing and begins to improve bone quality, with the aim of reducing the risk of further fractures.funzionale. In queste situazioni si hanno importanti risvolti sociali che vanno ad aggiungersi ai costi rilevanti di una frattura da fragilità. Nel quadriennio 1999-2002 i costi diretti totali attribuibili ai soli ricoveri ordinari (esclusa la riabilitazione) dei soggetti di età superiore a 65 anni oscillavano tra 341 e 394 milioni di euro per anno, con un incremento di circa il 15% nei quattro anni in esame. Nel quadriennio successivo i costi sono ulteriormente lievitati, tanto che per le fratture di femore ammontano a 586 milioni di euro/anno nella sola Italia e a 5 miliardi di euro in Europa [13]. Se si confrontano i costi della gestione di pazienti fratturati e non, ci si rende conto ulteriormente della portata del problema. Infatti il costo annuale per soggetto osteoporotico non fratturato negli Stati Uniti è di circa 7000 dollari, mentre per pazienti con fratture da fragilità il costo è più che triplicato. Inoltre i costi dei pazienti fratturati in età compresa fra 50 e 64 anni risultano essere significativamente maggiori di quelli sopra i 65 anni. Anche i costi dei vari tipi di fratture da fragilità variano in ordine decrescente dal femore alle vertebre e al polso. Tutto ciò suggerisce che l'orientamento clinico di fronte alla prima frattura da fragilità dovrebbe essere quello di prevenire un'ulteriore frattura trattando tempestivamente l'osteoporosi, anche per un risparmio dei costi socio-sanitari [14]. È stato rilevato che la durata media dei ricoveri ospedalieri per frattura di femore nell'anziano è la più lunga tra tutte le patologie acute. La durata della degenza media negli uomini variava da 14,2 giorni nel gruppo di età compresa tra 45 e 64 anni a 16,4 giorni nel gruppo di età compresa tra 65 e 74 anni; per le donne, la degenza media era...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.